Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis

Genes and Development

Volumn 10, Issue 24, 1996, Pages 3156-3169

  Bonten, Erik ^a   Van Der Spoel, Aarnoud ^a   Fornerod, Maarten ^a   Grosveld, Gerard ^a   D'Azzo, Alessandra ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

galactosialidosis; lysosome; mutations; Neuraminidase; protective protein cathepsin A; sialidosis

Indexed keywords

COMPLEMENTARY DNA; LYSOSOME ENZYME; SIALIDASE;

ARTICLE; CELLULAR DISTRIBUTION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 6P; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE EXPRESSION; GENE MUTATION; HUMAN; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; SIALIDOSIS;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0030451974     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.24.3156     Document Type: Article

References (80)

1. Andria, G., P. Strisciuglio, G. Pontarelli, W.S. Sly, and W.E. Dodson. 1981. Infantile neuraminidase and β-galactosidase deficiencies (galactosialidosis) with mild clinical courses. In Sialiadases and sialidoses (ed. P. Durand, G. Tettamanti, and S. DiDonato), pp. 379-395. Edi. Ermes, Milan, Italy.
2. Boguski, M.S. 1995. The turning point in genome research. Trends Biol. Sci. 20: 295-296.
3. Bonten, E.J., N.J. Galjart, R. Willemsen, M. Usmany, J.M. Vlak, and A. d'Azzo. 1995. Lysosomal protective protein/Cathepsin A: Role of the "linker" domain in catalytic activation. J. Biol. Chem. 270: 26441-26445.
4. Cantz, M. 1982. Sialidosis. In Sialic acids: Chemistry, metabolism, and function (ed. R. Schauer), pp. 307-320, Springer-Verlag, Vienna, Austria.
5. Chen, C. and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745-2752.
6. Chou, M.-Y., S.-C. Li, and Y.-T. Li. 1996. Cloning and expression of sialidase L, a NeuAcα2→3Gal-specific silaidase from the Leech, Macrobdella decora. J. Biol. Chem. 271: 19219-19224.
7. Colman, P.M. 1989. Neuraminidase enzyme and antigen. In The influenza viruses (ed. R.M. Klug), pp. 175-218, Plenum, New York, NY.
8. _. 1994. Influenza virus neuraminidase: Structure, antibodies, and inhibitors. Protein Sci. 3: 1687-1696.
9. Corfield, A.P., C.R. Lambre, J.-C. Michalski, and R. Schauer. 1992. Role of sialidases and sialic acids in molecular recognition phenomena. In Conferences Philippe Laudat 1991, pp. 113-134. Institut National de la Sante et de la Recherche Medicale, Paris, France.
10. Corfield, T. 1992. Bacterial sialidases - Roles in pathogenicity and nutrition. Glycobiology 2: 509-521.
11. Crennell, S.J., E.F. Garman, W.G. Laver, E.R. Vimr, and G.L. Taylor. 1993. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. Proc. Natl. Acad. Sci. 90: 9852-9856.
12. Crennell, S.J., E.F. Garman, C. Philippon, A. Vasella, W.G. Laver, E.R. Vimr, and G.L. Taylor. 1996. The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution. J. Mol. Biol. 259: 264-280.
13. d'Azzo, A., A. Hoogeveen, A.J. Reuser, D. Robinson, and H. Galjaard. 1982. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc. Natl. Acad. Sci. 79: 4535-4539.
14. d'Azzo, A., G. Andria, P. Strisciuglio, and H. Galjaard. 1995. Galactosialidosis. In The metabolic and molecular bases of inherited disease, Vol. 2 (ed. C. Scriver, A. Beaudet, W. Sly, and D. Valle), pp. 2825-2838. McGraw-Hill, New York, NY.
15. Ferrari, J., R. Harris, and T.G. Warner. 1994. Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: Sequence alignment similarities to bacterial sialidases. Glycobiology 4: 367-373.
16. Fingerhut, R., G.T.J. van der Horst, F.W. Verheijen, and E. Conzelmann. 1992. Degradation of gangliosides by the lysosomal sialidase requires an activator protein. Eur. J. Biochem. 208: 623-629.
17. Fornerod, M., J. Boer, S. van Baal, M. Jaegle, M. von Lindern, K.G. Murti, D. Davis, J. Bonten, A. Buijs, and G. Grosveld. 1995. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 10: 1739-1749.
18. Frisch, A. and E.F. Neufeld. 1979. A rapid and sensitive assay for neuraminidase: Application to cultured fibroblasts. Anal. Biochem. 95: 222-227.
19. Galen, J.E., J.M. Ketley, A. Fansano, S.H. Richardson, S.S. Wasserman, and J.B. Kaper. 1992. Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect. Immun. 60:406-415.
20. Galjaard, H. 1980. Genetic metabolic disease: Diagnosis and prenatal analysis. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
21. Galjart, N.J., N. Gillemans, A. Harris, G.T.J. van der Horst, F.W. Verheijen, H. Galjaard, and A. d'Azzo. 1988. Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: Homology to yeast proteases. Cell 54: 755-764.
22. Galjart, N.J., H. Morreau, R. Willemsen, N. Gillemans, E.J. Bonten, and A. d'Azzo. 1991. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J. Biol. Chem. 266: 14754-14762.
23. Gaskell, A., S. Crennell, and G. Taylor. 1995. The three domains of a bacterial sialidase: A β-propeller, an immunoglobulin module and a galactose-binding jelly-roll. Structure 3: 1197-1205.
24. Gluzman, Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23: 175-182.
25. Harada, F., Y. Nishimura, K. Suzuki, H. Matsumoto, T. Oohira, I. Matsuda, and T. Sasazuki. 1987. The patient with combined deficiency of neuraminidase and 21-hydroxylase. Hum. Genet. 75: 91-92.
26. Hermans, A., J. Gow, L. Selleri, M. von Lindern, A. Hagemeijer, L.M. Wiedemann, and G. Grosveld. 1988. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 2: 628-633.
27. Hoogeveen, A.T., F.W. Verheijen, and H. Galjaard. 1983. The relation between human lysosomal beta-galactosidase and its protective protein. J. Biol. Chem. 258: 12143-12146.
28. Hubbes, M., R.M. d'Agrosa, and J.W. Callahan. 1992. Human placental β-galactosidase. Characterization of the dimer and complex forms of the enzyme. Biochem. J. 285: 827-831.
29. Ioannou, Y.A., D.F. Bishop, and R.J. Desnick. 1992. Overexpression of human α-galactosidase A results in its intracellular aggregation, crystallization in lysosomes and selective secretion. J. Cell. Biol. 119: 1137-1150.
30. Kadowaki, T., H. Kadowaki, and S.I. Taylor. 1990. A nonsense mutation causing decreased levels of insulin receptor mRNA: Detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase in chain reaction. Proc. Natl. Acad. Sci. 87: 658-662.
31. Kuliawat, R. and P. Arvan. 1992. Protein targeting via the "constitutive-like" secretory pathway in isolated pancreatic islets: Passive sorting in the immature granule compartment. J. Cell. Biol. 118: 521-529.
32. Lieser, M., E. Harms, H. Kern, G. Bach, and M. Cantz. 1989. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties. Biochem. J. 260: 69-74.
33. Miyagi, T. and S. Tsuiki. 1985. Purification and characterization of cytosolic sialidase from rat liver. J. Biol. Chem. 260:6710-6716.
34. Miyagi, T., J. Sagawa, K. Konno, S. Handa, and S. Tsuiki. 1990a. Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain. J. Biochem. 107: 787-793.
35. Miyagi, T., J. Sagawa, K. Konno, and S. Tsuiki. 1990b. Immunological discrimination of intralysosomal, cytosolic, and two membrane sialidases present in rat tissues. J. Biochem. 107: 794-798.
36. Miyagi, T., K. Konno, Y. Emori, H. Kawasaki, K. Suzuki, A. Yasui, and S. Tsuiki. 1993. Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase. J. Biol Chem. 268: 26435-26440.
37. Morreau, H., N.J. Galjart, N. Gillemans, R. Willemsen, G.T.J. van der Horst, and A. d'Azzo. 1989. Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J. Biol. Chem. 264: 20655-20663.
38. Morris, S.W., M.B. Valentine, D.N. Shapiro, J.E. Sublett, L.L. Deaven, J.T. Foust, W.M. Roberts, D.P. Cerretti, and A.T. Look. 1991. Reassignment of the human CSF1 gene to chromosome 1p13-p21. Blood 27: 2013-2020.
39. Mueller, O.T., W.M. Henry, L.L. Haley, M.G. Byers, R.L. Eddy, and T.B. Shows. 1986. Sialidosis and galactosialidosis: Chromosomal assignment of two genes associated with neuraminidase-deficiency disorders. Proc. Natl. Acad. Sci. 83: 1817-1821.
40. Murphy, G. and T. Kavanagh. 1988. Speeding-up the sequencing of double-stranded DNA. Nucleic Acids Res. 16: 5198.
41. Okayama, H. and P. Berg. 1982. High-efficiency cloning of fulllength cDNA. Mol. Cell. Biol. 2: 161-170.
42. Oohira, T., N. Nagata, I. Akaboshi, I. Matsuda, and S. Naito. 1985. The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: Possible linkage between HLA and the neuraminidase deficiency gene. Hum. Genet. 70:341-343.
43. Potier, M., L. Michaud, J. Tranchemontagne, and L. Thauvette. 1990. Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex. Biochem. J. 267: 197-202.
44. Proia, R.L., A. d'Azzo, and E.F. Neufeld. 1984. Association of alpha- and beta-subunits during the biosynthesis of beta-hexosaminidase in cultured human fibroblasts. J. Biol. Chem. 259: 3350-3354.
45. Pshezhetsky, A.V. and M. Potier. 1994. Direct affinity purification and supramolecular organization of human lysosomal cathepsin A. Ach. Biochem. Biophys. 313: 64-70.
46. Reuter, G. and H.-J. Gabius. 1996. Review Sialic acids: Structure - analysis - metabolism - occurrence - recognition. Biol. Chem. Hoppe Seyler 377: 325-342.
47. Roggentin, P., B. Rothe, J.B. Kaper, J. Galen, L. Lawrisuk, E.R. Vimr, and R. Schauer. 1989. Conserved sequences in bacterial and viral sialidases. Glycoconj. J. 6: 349-353.
48. Roggentin, P., R. Schauer, L.L. Hoyer, and E.R. Vimr. 1993. MicroReview: The sialidase superfamily and its spread by horizontal gene transfer. Mol. Microbiol. 9: 915-921.
49. Rothe, B., B. Rothe, P. Roggentin, and R. Schauer. 1991. The sialidase gene from Clostridium septicum: Cloning, sequencing, expression in Escherichia coli and identification of conserved sequences in sialidases and other proteins. Mol. Gen. Genet. 226: 190-197.
50. Rusconi, S., Y. Severne, O. Georgiev, I. Galli, and S. Wieland. 1990. A novel expression assay to study transcriptional activators. Gene 89: 211-221.
51. Russell, P., S.O. Meakin, T.C. Hohman, L.C. Tsui, and M.L. Breitman. 1987. Relationship between proteins encoded by three human gamma-crystallin genes and distinct polypeptides in the eye lens. Mol. Cell. Biol. 7: 3320-3323.
52. Saito, M. and R.K. Yu. 1995. Biochemistry and function of sialidases. In Biology of the sialic acids (ed. A. Rosenberg), pp. 261-313, Plenum Press, New York, NY.
53. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
54. Sanger, F.G., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. 74: 5463-5467.
55. Sato, K. and T. Miyagi. 1995. Genomic organization and the 5′-upstream sequence of the rat cytosolic sialidase gene. Glycobiology 5: 511-516.
56. _. 1996. Involvement of an endogenous sialidase in skeletal muscle cell differentiation. Biochem. Biophys. Res. Commun. 221: 826-830.
57. Schauer, R., S. Kelm, G. Reuter, P. Roggentin, and L. Shaw. 1995. Biochemistry and role of sialic acids. In Biology of the sialic acids (ed. A. Rosenberg), pp. 7-67, Plenum Press, New York, NY.
58. Scheibe, R., K. Hein, and K.W. Wenzel. 1990. Lysosomal beta-galactosidase from rat liver: Purification, molecular forms and association with neuraminidase. Biomed. Biochim. Acta 49: 547-556.
59. Schenkman, S., D. Eichinger, M.E. Pereira, and V. Nussenzweig. 1994. Structural and functional properties of Trypanosoma trans-sialidase. Annu. Rev. Microbiol. 48: 499-523.
60. Schneider-Jakob, H.R. and M. Cantz. 1991. Lysosomal and plasma membrane ganglioside GM3 sialidases of cultured human fibroblasts - Differentiation by detergents and inhibitors. Biol. Chem. Hoppe Seyler 372: 443-450.
61. Smith, D.E. and P.A. Fisher. 1984. Identification, developmental regulation, and response to heat shock of two antigenically related forms of a major nuclear envelope protein in Drosophila embryos: Application of an improved method for affinity purification of antibodies using polypeptides immobilized on nitrocellulose blots. J. Cell. Biol. 99: 20-28.
62. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk. 1985. Measurement of protein using bicinchoninic acid [published erratum appears in Anal. Biochem. 163: 279, 1987]. Anal. Biochem. 150: 76-85.
63. Tettamanti, G., I.G. Morgan, G. Gombos, G. Vincendon, and P. Mandai. 1972. Sub-synaptosomal localization of brain particulate neuraminidase. Brain Res. 47: 515-518.
64. Thomas, G.H. and A.L. Beaudet. 1995. Disorders of glycoprotein degradation and structure: α-mannosidosis, β-mannosidosis, fucosidosis, sialidosis, aspartylglucosaminuria and carbohydrate-deficient glycoprotein syndrome. In The metabolic and molecular bases of inherited disease (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 2529-2561, McGraw-Hill, Inc., New York, NY.
65. van der Horst, G., N.J. Galjart, A. d'Azzo, H. Galjaard, and F.W. Verheijen. 1989. Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta. J. Biol. Chem. 264: 1317-1322.
66. van Dongen, J.M., R. Willemsen, E.I. Ginns, H.J. Sips, f.M. Tager, J.A. Barranger, and A.J. Reuser. 1985. The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: A comparative immunocytochemical study. Eur. J. Cell. Biol. 39: 179-189.
67. van Pelt, J., J.P. Kamerling, J.F. Vliegenthart, A.T. Hoogeveen, and H. Galjaard. 1988a. A comparative study of the accumulated sialic acid-containing oligosaccharides from cultured human galactosialidosis and sialidosis fibroblasts. Clin. Chim. Acta 174: 325-335.
68. van Pelt, J., J.P. Kamerling, J.F. Vliegenthart, F.W. Verheijen, and H. Galjaard. 1988b. Isolation and structural characterization of sialic acid-containing storage material from mucolipidosis I (sialidosis) fibroblasts. Biochim. Biophys. Acta 965: 36-45.
69. van Pelt, J., D.G. van Bilsen, J.P. Kamerling, and J.F. Vliegenthart. 1988c. Structural analysis of O-glycosidic type of sialyloligosaccharide-alditols derived from urinary glycopeptides of a sialidosis patient. Eur. J. Biochem. 174: 183-187.
70. Verheijen, F., R. Brossmer, and H. Galjaard. 1982. Purification of acid beta-galactosidase and acid neuraminidase from bovine testis: Evidence for an enzyme complex. Biochem. Biophys. Res. Commun. 108: 868-875.
71. Verheijen, F.W., S. Palmeri, A.T. Hoogeveen, and H. Galjaard. 1985. Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein. Eur. J. Biochem. 149:315-321.
72. Verheijen, F.W., S. Palmeri, and H. Galjaard. 1987. Purification and partial characterization of lysosomal neuraminidase from human placenta. Eur. J. Biochem. 162: 63-67.
73. von Heijne, G. 1986. A new method for predicting signal sequence cleavage sites. Nucliec Acids Res. 14: 4683-4690.
74. Warner, T.G., A. Louie, and M. Potier. 1990. Photolabeling of the alpha-neuraminidase/beta-galactosidase complex from human placenta with a photoreactive neuraminidase inhibitor. Biochem. Biophys. Res. Commun. 173: 13-19.
75. Warner, T.G., J. Chang, J. Ferrari, R. Harris, T. McNerney, G. Bennett, J. Burnier, and M.B. Sliwkowski. 1993. Isolation and properties of a soluble sialidase from the culture fluid of Chinese hamster ovary cells. Glycobiology 3: 455-463.
76. Wenger, D.A., T.J. Tarby, and C. Wharton. 1978. Macular cherry-red spots and myoclonus with dementia: Coexistent neuraminidase and β-galactosidase deficiencies. Biochem. Biophys. Res. Commun. 82: 589-595.
77. Womack, J.E., D.L. Van, and M. Potier. 1981. Gene for neuraminidase activity on mouse chromosome 17 near h-2: Pleiotropic effects on multiple hydrolases. Science 212: 63-65.
78. Yamamoto, Y. and K. Nishimura. 1987. Copurification and separation of beta-galactosidase and sialidase from porcine testis. Int. J. Biochem. 19: 435-442.
79. Zeigler, M., V. Sury, and G. Bach. 1989. The identification of lysosomal ganglioside sialidase in human cells. Eur. J. Biochem. 183: 455-458.
80. Zhou, X.Y., H. Morreau, R. Rottier, D. Davis, E. Bonten, N. Gillemans, D. Wenger, F.G. Grosveld, P. Doherty, K. Suzuki, G.C. Grosveld, and A. d'Azzo. 1995. Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with over-expressing erythroid precursor cells. Genes & Dev. 9: 2623-2634.